Vimal Mehta Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

Vimal Mehta is CEO and President of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 20,876 shares of BTAI, which is worth approximately $34,027. The most recent transaction as insider was on Jun 15, 2023, when has been sold 30,000 shares (Common Stock) at a price of $21.66 per share, resulting in proceeds of $649,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.9K
1.87% 3M change
64.98% 12M change
Total Value Held $34,027

Vimal Mehta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
SELL
Open market or private sale
$649,800 $21.66 p/Share
30,000 Reduced 42.92%
39,903 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
$12,300 $0.41 p/Share
30,000 Added 30.03%
69,903 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
-
2,609 Added 6.14%
39,903 Common Stock
May 22 2023
SELL
Open market or private sale
$167,635 $25.79 p/Share
6,500 Reduced 14.84%
37,294 Common Stock
May 14 2023
BUY
Exercise of conversion of derivative security
-
15,000 Added 32.68%
30,894 Common Stock
Mar 21 2023
SELL
Open market or private sale
$597,900 $19.93 p/Share
30,000 Reduced 65.37%
15,894 Common Stock
Mar 21 2023
BUY
Exercise of conversion of derivative security
$12,300 $0.41 p/Share
30,000 Added 39.53%
45,894 Common Stock
Mar 20 2023
SELL
Open market or private sale
$639,630 $18.54 p/Share
34,500 Reduced 68.46%
15,894 Common Stock
Mar 20 2023
BUY
Exercise of conversion of derivative security
$12,300 $0.41 p/Share
30,000 Added 37.32%
50,394 Common Stock
Mar 14 2023
BUY
Exercise of conversion of derivative security
-
10,437 Added 33.85%
20,394 Common Stock
Dec 16 2022
SELL
Open market or private sale
$587,100 $19.57 p/Share
30,000 Reduced 75.08%
9,957 Common Stock
Dec 16 2022
BUY
Exercise of conversion of derivative security
$12,300 $0.41 p/Share
30,000 Added 42.88%
39,957 Common Stock
Dec 15 2022
SELL
Open market or private sale
$600,900 $20.03 p/Share
30,000 Reduced 75.08%
9,957 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$12,300 $0.41 p/Share
30,000 Added 42.88%
39,957 Common Stock
Jul 24 2020
BUY
Other acquisition or disposition
$4,860,800 $60.76 p/Share
80,000 Added 50.0%
80,000 Common Stock
VM

Vimal Mehta

CEO and President
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI